{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:37:44Z","timestamp":1793147864499,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.amjms.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T15:13:37Z","timestamp":1615216417000},"page":"683-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity"],"prefix":"10.1016","volume":"361","author":[{"given":"Kanak","family":"Parmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjms.2021.03.003_bib0001","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.003_bib0002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.003_bib0003","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/archdischild-2016-310760","article-title":"BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial","volume":"102","author":"Stensballe","year":"2017","journal-title":"Arch Dis Child"},{"issue":"12","key":"10.1016\/j.amjms.2021.03.003_bib0004","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cmi.2019.06.002","article-title":"Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria","volume":"25","author":"dos Santos","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.amjms.2021.03.003_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jb.92.1.1-5.1966","article-title":"Stimulation of nonspecific resistance to infection by a crude cell wall preparation from Mycobacterium phlei","volume":"92","author":"Fox","year":"1966","journal-title":"J Bacteriol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.119.1.53","article-title":"Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). I antimicrobial protection","volume":"119","author":"Weiss","year":"1964","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.amjms.2021.03.003_bib0007","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.amjms.2021.03.003_bib0008","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.urology.2004.09.025","article-title":"Application of viable bacilleCalmette-Guerin topically as a potential therapeutic modality in condyloma acuminata: a placebo-controlled study","volume":"65","author":"Metawea","year":"2005","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.003_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/ijd.IJD_558_16","article-title":"Bacillus calmette-guerin immunotherapy for recurrent multiple warts: an open-label uncontrolled study","volume":"64","author":"Jaisinghani","year":"2019","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0011","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/190889a0","article-title":"Protective activity of fractions of tubercle bacilli against isologoustumours in mice","volume":"190","author":"Weiss","year":"1961","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.amjms.2021.03.003_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"issue":"8","key":"10.1016\/j.amjms.2021.03.003_bib0013","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/JVI.02393-08","article-title":"CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses","volume":"83","author":"Mathurin","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0014","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3389\/fimmu.2018.02869","article-title":"Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations","volume":"9","author":"Uthayakumar","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1525-1470.2012.01848.x","article-title":"Treatment of common and plane warts in children with topical viable Bacillus Calmette-Guerin","volume":"30","author":"Salem","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0016","doi-asserted-by":"crossref","first-page":"109e14","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.amjms.2021.03.003_bib0017","first-page":"2782e90","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.amjms.2021.03.003_bib0018","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"issue":"43","key":"10.1016\/j.amjms.2021.03.003_bib0019","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Epigenetic reprogramming of monocytes by BCG","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.003_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"6204","key":"10.1016\/j.amjms.2021.03.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.amjms.2021.03.003_bib0022","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis Bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"30","key":"10.1016\/j.amjms.2021.03.003_bib0023","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2013.03.059","article-title":"Non-specific effect of Bacille Calmette-Gu\u00e9rin vaccine on the immune response to routine immunizations","volume":"31","author":"Ritz","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.003_bib0024","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10096-020-03813-y","article-title":"Differential effects of BCG vaccine on immune responses induced by vi polysaccharide typhoid fever vaccination: an explorative randomized trial","volume":"39","author":"Blok","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2021.03.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180143","article-title":"Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.amjms.2021.03.003_bib0026","first-page":"185e90","article-title":"The efficacy of BacillusCalmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.amjms.2021.03.003_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WOX.0b013e31816c8b85","article-title":"Clinical efficacy and laboratory improvement of bacillus Calmette Guerin vaccination on adults atopic asthma","volume":"14","author":"Datau","year":"2008","journal-title":"World Allergy Organ J"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.003_bib0028","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1399-3038.2007.00669.x","article-title":"Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination","volume":"19","author":"Rousseau","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"issue":"52","key":"10.1016\/j.amjms.2021.03.003_bib0029","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.amjms.2021.03.003_bib0030","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/JVI.80.4.1645-1652.2006","article-title":"Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env","volume":"80","author":"Cayabyab","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0031","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2?","volume":"11","author":"Covi\u00e1n","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2021.03.003_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.puhe.2020.05.042","article-title":"TB infection and BCG vaccination: are we protected from COVID-19?","volume":"185","author":"Madan","year":"2020","journal-title":"Public Health"},{"key":"10.1016\/j.amjms.2021.03.003_bib0033","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SAR-CoV-2 rates in BCG Vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amjms.2021.03.003_bib0034","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1164\/rccm.201908-1506PP","article-title":"Reconsidering the optimal immune response to mycobacterium tuberculosis","volume":"201","author":"Tezera","year":"2020","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:39:17Z","timestamp":1757702357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0002962921000926"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.03.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}